Tumorigenesis associated with increased PFKFB3 transcription or with enhanced PFKFB3 phosphorylation has been shown to be implicated in ER+, PR+, HER2+, and recurrent breast cancer cells [40,41,54,66,72]. Here, ERBB2 is linked to breast cancer.